Th17 responses in chronic allergic airway inflammation abrogate regulatory T-cell-mediated tolerance and contribute to airway remodeling
- 15 August 2012
- journal article
- research article
- Published by Elsevier BV in Mucosal Immunology
- Vol. 6 (2), 335-346
- https://doi.org/10.1038/mi.2012.76
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Phenotypic and Functional Properties of Helios+ Regulatory T CellsPLOS ONE, 2012
- Signal peptide cleavage is essential for surface expression of a regulatory T cell surface protein, leucine rich repeat containing 32 (LRRC32)BMC Biochemistry, 2011
- Resolution of Allergic Airway Inflammation and Airway Hyperreactivity Is Mediated by IL-17–producing γδT CellsAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Th17 Immunity in Patients with Allergic AsthmaInternational Archives of Allergy and Immunology, 2009
- Pathophysiological Features of Asthma Develop in Parallel in House Dust Mite–Exposed Neonatal MiceAmerican Journal of Respiratory Cell and Molecular Biology, 2009
- GARP (LRRC32) is essential for the surface expression of latent TGF-β on platelets and activated FOXP3 + regulatory T cellsProceedings of the National Academy of Sciences of the United States of America, 2009
- IL-17 and Th17 CellsAnnual Review of Immunology, 2009
- Suppression of allergic airway inflammation and IgE responses by a class I restricted allergen peptide vaccineMucosal Immunology, 2008
- Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammationNature Medicine, 2008
- Interleukin-17 is a negative regulator of established allergic asthmaThe Journal of Experimental Medicine, 2006